Dr. Reddy's Laboratories reports 9% fall in Q2 consolidated net profit

06 Nov 2024 Evaluate

Dr. Reddy's Laboratories has reported results for second quarter ended September 30, 2024 (Q2FY25).

The company has reported 57.81% rise in its net profit at Rs 1882.10 crore for the quarter ended September 30, 2024 as compared to Rs 1192.60 crore for the same quarter in the previous year. Total income of the company increased by 36.39% at Rs 6903.90 crore for Q2FY25 as compared to Rs 5061.80 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 9.47% fall in net profit at Rs 1341.90 crore for Q2FY25 as compared to Rs 1482.20 crore for the same quarter in the previous year. However, total income of the company increased by 15.63% at Rs 8345.70 crore for Q2FY25 as compared to Rs 7217.60 crore for the corresponding quarter previous year.

Dr. Reddys Lab Share Price

1194.55 -19.40 (-1.60%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.